Drug profile · INN
lurasidone
APO-LURASIDONE
lurasidone (APO-LURASIDONE) is a dopamine d2 receptor antagonist. Associated with Alphapharm Pty Ltd.
EMA: approved TGA: approved Nervous system (N05) N05AE05
Patents linked 1
Pipeline programs 3
News articles 0
Drug details — lurasidone
- Class
- Nervous system (N05)
- Route
- —
- Patents
- 1
- Programs
- 3
- Data quality
- 0.83
Quick answer
lurasidone (APO-LURASIDONE) is a dopamine d2 receptor antagonist. Associated with Alphapharm Pty Ltd.
Key facts
INN lurasidone
Brand APO-LURASIDONE
Mechanism Dopamine D2 receptor antagonist
Therapeutic class Nervous system (N05)
ATC code N05AE05
Originator Alphapharm Pty Ltd
Mechanism of action
Dopamine D2 receptor antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is lurasidone?
lurasidone (APO-LURASIDONE) is a dopamine d2 receptor antagonist. Associated with Alphapharm Pty Ltd.
What is the brand name for lurasidone?
APO-LURASIDONE is a marketed brand name for lurasidone. Check FDA Drugs@FDA for the current US label holder and prescribing information.